Published in J Thorac Cardiovasc Surg on April 01, 2004
Minimally invasive mitral surgery through right mini-thoracotomy under direct vision. J Thorac Dis (2013) 0.89
Clinical results of minimally invasive open-heart surgery in patients with mitral valve disease: comparison of parasternal and low-sternal approach. Yonsei Med J (2006) 0.78
Numerical simulation of blood flow in femoral perfusion: comparison between side-armed femoral artery perfusion and direct femoral artery perfusion. J Artif Organs (2016) 0.77
Minimally invasive approach for redo mitral valve surgery. J Thorac Dis (2013) 0.75
Minimal invasive coronary artery fistula ligation. Korean J Thorac Cardiovasc Surg (2014) 0.75
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation (2007) 3.05
A novel technique for vacuum assisted closure device application in noncontiguous wounds. J Plast Reconstr Aesthet Surg (2006) 2.61
Simulating video-assisted thoracoscopic lobectomy: a virtual reality cognitive task simulation. J Thorac Cardiovasc Surg (2011) 2.38
30-day readmissions after coronary artery bypass graft surgery in New York State. JACC Cardiovasc Interv (2011) 2.09
Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation (2012) 1.83
Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates? Circulation (2003) 1.80
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett (2008) 1.71
Long-term mortality of coronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg (2011) 1.60
Minimally invasive mitral valve surgery: a 6-year experience with 714 patients. Ann Thorac Surg (2002) 1.56
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg (2013) 1.54
The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery. Ann Thorac Surg (2012) 1.51
Failure of four bovine pericardial mitral prostheses. J Thorac Cardiovasc Surg (2004) 1.50
Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg (2007) 1.47
Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol (2006) 1.43
Aortic valve replacement for patients with severe aortic stenosis: risk factors and their impact on 30-month mortality. Ann Thorac Surg (2009) 1.42
The relationship between perioperative temperature and adverse outcomes after off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2010) 1.42
Ten-year results of folding plasty in mitral valve repair. Ann Thorac Surg (2010) 1.41
VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A (2006) 1.40
Mitral valve disease presentation and surgical outcome in African-American patients compared with white patients. Ann Thorac Surg (2008) 1.40
Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem (2007) 1.40
Regional changes in coaptation geometry after reduction annuloplasty for functional mitral regurgitation. Ann Thorac Surg (2012) 1.39
Off-pump coronary artery bypass grafting: single center experience with 1,000 consecutive patients. Isr Med Assoc J (2004) 1.38
Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem (2007) 1.27
High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg (2008) 1.27
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J (2002) 1.27
HER 2/neu expression and gene amplification in colon cancer. Int J Cancer (2003) 1.26
Evolution of operative techniques and perfusion strategies for minimally invasive mitral valve repair. J Thorac Cardiovasc Surg (2012) 1.26
A decade of minimally invasive mitral repair: long-term outcomes. Ann Thorac Surg (2009) 1.24
Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol (2010) 1.20
A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol (2004) 1.18
Paradoxical septal motion after cardiac surgery: a review of 3,292 cases. Clin Cardiol (2007) 1.17
Minimally invasive valve surgery with antegrade perfusion strategy is not associated with increased neurologic complications. Ann Thorac Surg (2011) 1.14
Minimally invasive aortic valve surgery in the elderly: a case-control study. Circulation (2003) 1.13
Propensity score analysis of a six-year experience with minimally invasive isolated aortic valve replacement. J Heart Valve Dis (2004) 1.10
Retrograde arterial perfusion, not incision location, significantly increases the risk of stroke in reoperative mitral valve procedures. Ann Thorac Surg (2010) 1.07
Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg (2010) 1.06
Minimally invasive reoperative isolated valve surgery: early and mid-term results. J Card Surg (2006) 1.04
Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol (2005) 1.01
Correlation between plasma osteopontin levels and aortic valve calcification: potential insights into the pathogenesis of aortic valve calcification and stenosis. J Thorac Cardiovasc Surg (2009) 1.01
Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg (2003) 1.00